Cost-effectiveness of First-Line Immunotherapy Combinations with or Without Chemotherapy for Advanced Non-Small Cell Lung Cancer: a Modelling Approach.
BMC CANCER（2023）
关键词
Cost-effectiveness,Non-small cell lung cancer,Immunotherapy combination,Hazard ratio,Partitioned survival model
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要